Structure-based rational design uses structural data from X-ray crystallography, NMR spectroscopy, or computational modeling to guide the optimization of peptide binding affinity and selectivity. This approach is efficient for optimizing lead compounds and has been successfully applied to numerous peptide therapeutics.
The structure-based design process begins with a structure of the peptide bound to its target. This structure reveals the interactions that contribute to binding, including hydrogen bonds, hydrophobic contacts, and electrostatic interactions. Analysis of these interactions identifies positions where modifications could improve binding.
Rational design strategies include optimizing interactions at key positions, introducing constraints to stabilize the bioactive conformation, and modifying the peptide to reduce unfavorable interactions. Computational modeling can predict the effects of modifications before synthesis, reducing the number of variants that need to be synthesized and tested.
Molecular docking and molecular dynamics simulations are commonly used in structure-based design. Docking predicts how peptides bind to targets, while dynamics simulations explore the conformational flexibility of the peptide-target complex. These computational approaches guide the selection of modifications for synthesis.
Applications of structure-based design include optimizing peptide leads for potency and selectivity, designing peptides for challenging targets, and developing peptides with improved pharmacokinetic properties. The approach has been successfully applied to numerous peptide therapeutics, demonstrating its utility for drug discovery. At PeptideHub, we employ molecular modeling and docking to predict favorable mutations, synthesizing and testing variants to achieve high-affinity peptide candidates.